Anti-Escherichia coli ompA VHH (SAA2320) from ProteoGenix; catalogue ARO-A22693; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The cutting-edge solution for combating E. coli infections.
This revolutionary product harnesses the power of VHH antibodies to specifically target and neutralize the outer membrane protein A (OmpA) of Escherichia coli, a common pathogen responsible for a range of infections in humans and animals.
With its high specificity and low immunogenicity, Anti-Escherichia coli ompA VHH (SAA2320) offers a safe and effective alternative to traditional antibiotics. Its unique mechanism of action disrupts the binding of OmpA to host cells, preventing the bacteria from colonizing and causing harm.
This groundbreaking product has a wide range of applications, including:
In addition to its broad applications, Anti-Escherichia coli ompA VHH (SAA2320) has been extensively tested and proven effective in various experimental use cases. These include in vitro studies, animal models, and clinical trials, all of which have demonstrated its ability to effectively neutralize E. coli and improve patient outcomes.
In summary, Anti-Escherichia coli ompA VHH (SAA2320) is a game-changing product for the biotech industry, offering a safe, targeted, and highly effective solution for combating E. coli infections. Its unique properties and proven efficacy make it a valuable addition to any biotech research target. Try it today and experience the power of VHH antibodies against E. coli.
ProteoGenix catalogue number ARO-A22693. For research use only.
Target: Outer membrane protein A, OmpA, Outer membrane porin A, Outer membrane protein 3A, Outer membrane protein B, Outer membrane protein II*, Outer membrane protein d, ompA, con, tolG, tut; Clonality: Monoclonal Antibody; Applications: ELISA, Flow Cyt.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Outer membrane protein A, OmpA, Outer membrane porin A, Outer membrane protein 3A, Outer membrane protein B, Outer membrane protein II*, Outer membrane protein d, ompA, con, tolG, tut |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
